Amwill Healthcare came to market through an SME IPO that opened on 5 February 2025 and closed on 7 February 2025, and the shares listed on 12 February 2025 on BSE SME. The price band was ₹105 to ₹111 per share and one lot was 1200 shares, so the minimum application was ₹1,33,200. The issue size was ₹59.98 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
Bigshare Services Pvt Ltd was the registrar to the issue, and Unicon Capital Services Private Ltd was the lead manager.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that partners with contract manufacturers, distributors, and third-party product development agencies. This partnership has helped the company improve its manufacturing, packaging, and distribution capacity. The Company's product portfolio is categorized into two segments, namely, Generic dermatological solutions development and Formulation of targeted solutions for dermatological conditions.
The company markets its products in Karnataka, Andhra Pradesh and Telangana, focusing on strengthening its presence before entering new markets to build a customer base. The company develops products for dermatological disorders, including acne, fungal infections, anti-ageing, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo. As of April 30, 2024, the company has 31 employees in its marketing team. As of April 30, 2024, the company has 59 employees on payroll.
As described in the offer document.
| Metric | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 |
|---|
Anand Gandhi, Tarun Gandhi. Promoter holding 97.00% before the issue.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Amwill Healthcare IPO was a ₹59.98 crore book-built issue, comprising a fresh issue of ₹48.88 crore and an offer for sale of ₹11.1 crore. It was priced at ₹105–₹111 per share with a lot size of 1,200 shares (₹1,33,200). The IPO was open from February 5 to February 7, 2025. Shares listed on BSE SME on February 12, 2025 at ₹88.85, a 20.0% discount to the issue price of ₹111. Bigshare Services Pvt Ltd is the registrar.
Unicon Capital Services Private Ltd is the book running lead manager.
The price band of Amwill Healthcare IPO is ₹105 to ₹111 per share.
The lot size of Amwill Healthcare IPO is 1200 shares.
The minimum investment for Amwill Healthcare IPO is approximately ₹1,33,200 based on the upper price band.
The allotment date of Amwill Healthcare IPO is Feb 10, 2025.
Amwill Healthcare IPO's final recorded GMP before listing was ₹1 per share (a 1% premium over the ₹111 upper price band). The shares listed at ₹88.85. GMP is unofficial and does not forecast or guarantee the actual listing price.
You can check Amwill Healthcare IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Amwill Healthcare IPO allotment status on Rupix for quick and easy access.
₹105 to ₹111 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 1200 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,33,200. After listing, SME shares also trade in lots rather than one share at a time.
₹1,33,200, for one lot of 1200 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 5 February 2025 and closed on 7 February 2025.
The basis of allotment was published on 10 February 2025 by Bigshare Services Pvt Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 12 February 2025 on BSE SME.
The issue size was ₹59.98 crore. The fresh issue was 44,03,600 shares (aggregating up to ₹48.88 crore). The offer for sale was 10,00,000 shares (aggregating up to ₹11.1 crore).